Thrombolytic Therapy for Acute Ischemic Stroke: Why the Majority of Patients Remain Ineligible for Treatment
- 1 January 1999
- journal article
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 33 (1) , 9-14
- https://doi.org/10.1016/s0196-0644(99)70411-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rapid Response to Stroke Symptoms: The Delay in Accessing Stroke Healthcare (DASH) StudyAcademic Emergency Medicine, 1998
- A Systems Approach to Immediate Evaluation and Management of Hyperacute StrokeStroke, 1997
- Streptokinase for Acute Ischemic Stroke With Relationship to Time of AdministrationJAMA, 1996
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic strokeThe Lancet, 1995
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995
- Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.Stroke, 1994
- Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST).Stroke, 1994
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992